Advertisement
New Zealand markets close in 36 minutes
  • NZX 50

    11,817.97
    -128.46 (-1.08%)
     
  • NZD/USD

    0.5956
    +0.0007 (+0.11%)
     
  • NZD/EUR

    0.5549
    +0.0009 (+0.16%)
     
  • ALL ORDS

    7,851.10
    -86.40 (-1.09%)
     
  • ASX 200

    7,589.60
    -93.40 (-1.22%)
     
  • OIL

    83.85
    +0.28 (+0.34%)
     
  • GOLD

    2,347.10
    +4.60 (+0.20%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,626.75
    +342.21 (+1.98%)
     
  • NIKKEI 225

    37,888.47
    +259.99 (+0.69%)
     
  • NZD/JPY

    92.9530
    +0.4570 (+0.49%)
     

Biotech Stocks Are Already Risky -- Now There Are 3 New Headwinds to Face in 2023

Biotech Stocks Are Already Risky -- Now There Are 3 New Headwinds to Face in 2023

Biotech investors love to take on oodles of risk in hopes of getting an outsized reward when one of their bets finally pays off. While NHPs account for only 0.5% of the animal models used in biomedicine, biotechs and other researchers in the U.S. have faced a shortage of NHPs since at least 2019.